CARPL.ai
Category: AI in Healthcare
World's largest vendor-neutral radiology AI marketplace and enterprise imaging platform for discovering, testing, deploying, and monitoring medical imaging AI applications. CARPL.ai was founded in 2018. The company is led by Dr. Vidur Mahajan. Based in Delhi, India (India registered / Global HQ per Indian press); Cupertino, California (US operational HQ); Wilmington, Delaware (US registered); Singapore. Team size: 51-100. Total funding raised: $16M. Latest round: Series A. Key investors include International Finance Corporation (IFC) - World Bank Group, Stellaris Venture Partners, Angel investors from Novo Holdings, Leapfrog PE, Bain & Co., Boston Consulting Group, United HealthGroup.
- Founded
- 2018
- Headquarters
- Delhi, India (India registered / Global HQ per Indian press); Cupertino, California (US operational HQ); Wilmington, Delaware (US registered); Singapore
- Team size
- 51-100
- Total funding
- $16M
Value proposition
CARPL.ai provides a single integration point, single user interface, and single procurement channel that enables hospitals and radiologists to access, assess, validate, deploy, and monitor 300+ AI applications from 100+ AI vendors across their clinical workflows — eliminating the need for costly and time-consuming individual integrations with each AI vendor.
Products and solutions
1) AI Marketplace (300+ AI apps from 100+ vendors), 2) Universal AI Viewer (infrastructure-agnostic), 3) DEV-D Framework (Discover, Explore, Validate, Deploy), 4) AI Testing & Validation Platform, 5) AI Performance Monitoring, 6) Enterprise-Grade Deployment (on-premise or cloud), 7) PACS/RIS integration, 8) Research & Validation Studies platform
Unique value
Only platform combining the world's largest radiology AI marketplace with pre-deployment validation and post-deployment monitoring capabilities, integrated directly with radiologists' PACS workstations — all through a single vendor-neutral integration.
Target customer
Hospitals, radiology practices, health systems, PACS vendors, AI developers, and government healthcare programs globally
Industries served
Radiology / Medical Imaging (primary), expanding into digital pathology, oncology, cardiology, dermatology, ophthalmology, gastroenterology
Technology advantage
Vendor-neutral platform; FDA 510(k) cleared; ISO 27001 and ISO 13485 certified; regulatory clearances across FDA (US), CE (Europe), ANVISA (Brazil), TGA (Australia), HSA (Singapore); proprietary DEV-D framework; single integration pipeline eliminating 6-18 month per-vendor integration cycles; cloud and on-premise deployment flexibility
How they differentiate
Only platform offering both pre-deployment validation AND post-deployment monitoring with PACS workstation integration; largest AI marketplace (300+ apps vs competitors' smaller catalogs); vendor-neutral approach; proprietary DEV-D framework; regulatory clearances across multiple global regions
Main competitors
Blackford Analysis, DeepC, Incepto
Key partnerships
Agfa HealthCare (RUBEE AI powered by CARPL), Intelerad (AI partner ecosystem), DeepHealth/RadNet (strategic AI control system collaboration), Philips (Brazilian healthcare system), PaxeraHealth (ARK no-code AI authoring integration), Enlitic (AI validation acceleration), Ramsoft
Notable customers
Singapore Government, RadNet/DeepHealth, I-MED Radiology, Massachusetts General Hospital, Radiology Partners, University Hospitals (Cleveland), Albert Einstein Hospital, Fleury (Brazil), Medica, Clinton Health Access Initiative, Government of India (TB screening programs)
Major milestones
2018: Company founded by Dr. Vidur Mahajan, 2021: Platform operational, 2024: $6M Seed round led by Stellaris Venture Partners, 2024: Partnerships with DeepHealth/RadNet and AGFA HealthCare, 2025: Partnership with Intelerad, 2025: Partnership with PaxeraHealth, 2026: $10M Series A led by IFC, 2026: Partnership with Enlitic
Growth metrics
300+ AI applications from 100+ AI vendors on marketplace; 30+ hospitals and medical centers as customers; operations across North America, Europe, Middle East, India, Southeast Asia, Australia, Latin America
Market positioning
Positioned as the world's largest radiology AI marketplace and the leading AI orchestration layer for enterprise imaging — an AI platform-layer play that sits between AI developers and healthcare providers, reducing friction in AI adoption.
Geographic focus
Global: North America (US), Europe, Middle East, India, Southeast Asia (Singapore), Australia, Latin America (Brazil)
About Dr. Vidur Mahajan
Ex-Associate Director at Mahajan Imaging Pvt. Ltd. (family business, grew revenue 10x to $20M in 10 years); Physician (MBBS, AIIMS); MBA from The Wharton School, University of Pennsylvania; Published in The Lancet
Latest news about CARPL.ai
More AI in Healthcare companies
Official website: https://carpl.ai
